X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (119) 119
hiv infections - drug therapy (92) 92
adult (78) 78
infectious diseases (75) 75
female (73) 73
male (73) 73
viral load (58) 58
middle aged (55) 55
hiv infections - virology (54) 54
virology (52) 52
anti-hiv agents - therapeutic use (47) 47
immunology (46) 46
cd4 lymphocyte count (37) 37
drug therapy, combination (35) 35
reverse transcriptase inhibitors - therapeutic use (34) 34
antiretroviral therapy, highly active (33) 33
hiv (33) 33
hiv-1 - drug effects (33) 33
pharmacology & pharmacy (32) 32
treatment outcome (31) 31
antiretroviral therapy (30) 30
hiv-1 (29) 29
hiv infections - immunology (27) 27
drug therapy (26) 26
hiv infection (25) 25
rna, viral - blood (25) 25
cohort studies (24) 24
hiv-1 - genetics (24) 24
index medicus (24) 24
aids (23) 23
hiv protease inhibitors - therapeutic use (23) 23
medicine, general & internal (21) 21
aged (19) 19
microbiology (19) 19
mortality (18) 18
mutation (18) 18
antiviral agents (16) 16
genotype (16) 16
risk factors (16) 16
zidovudine - therapeutic use (16) 16
adolescent (15) 15
lamivudine - therapeutic use (15) 15
resistance (15) 15
zidovudine (15) 15
anti-hiv agents - pharmacology (14) 14
disease progression (14) 14
treatment failure (14) 14
europe (13) 13
therapy (13) 13
cohort (12) 12
combination therapy (12) 12
drug resistance, viral (12) 12
human-immunodeficiency-virus (12) 12
prospective studies (12) 12
time factors (12) 12
antiretroviral drugs (11) 11
hiv infections - mortality (11) 11
hiv-1 - isolation & purification (11) 11
hiv-1-infected patients (11) 11
infected patients (11) 11
lamivudine (11) 11
phenotype (11) 11
research (11) 11
reverse transcriptase inhibitors - pharmacology (11) 11
combination (10) 10
highly active antiretroviral therapy (10) 10
hiv infections - complications (10) 10
hiv-1 - physiology (10) 10
hiv-infected patients (10) 10
human immunodeficiency virus--hiv (10) 10
protease inhibitors (10) 10
tenofovir (10) 10
adenine - analogs & derivatives (9) 9
anti-hiv agents - administration & dosage (9) 9
anti-retroviral agents - therapeutic use (9) 9
dideoxynucleosides - therapeutic use (9) 9
drug administration schedule (9) 9
drug-resistance (9) 9
immunodeficiency-virus type-1 (9) 9
ritonavir (9) 9
ritonavir - therapeutic use (9) 9
acquired immunodeficiency syndrome - drug therapy (8) 8
adenine - therapeutic use (8) 8
adults (8) 8
aids/hiv (8) 8
dosage and administration (8) 8
double-blind method (8) 8
drug resistance (8) 8
drug resistance, viral - genetics (8) 8
europe - epidemiology (8) 8
hiv-infection (8) 8
human immunodeficiency virus (8) 8
in-vitro (8) 8
infection (8) 8
prognosis (8) 8
proportional hazards models (8) 8
anti-hiv agents - adverse effects (7) 7
article (7) 7
drug interactions (7) 7
drug resistance, microbial - genetics (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9672, pp. 1352 - 1363
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 07/2002, Volume 360, Issue 9327, pp. 119 - 129
Journal Article
Journal Article
AIDS (London, England), ISSN 0269-9370, 2007, Volume 21, Issue 9, pp. 1185 - 1197
Journal Article
JAMA, ISSN 0098-7484, 03/2001, Volume 285, Issue 9, pp. 1155 - 1163
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9534, pp. 476 - 482
Lopinavir-ritonavir is a preferred protease inhibitor co-formulation for initial HIV-1 treatment. Fosamprenavir-ritonavir has shown similar efficacy and safety... 
MEDICINE, GENERAL & INTERNAL | THERAPY | NAIVE PATIENTS | RECOMMENDATIONS | EFAVIRENZ | TENOFOVIR DF | RESISTANCE | AIDS | SOCIETY-USA PANEL | LOPINAVIR/RITONAVIR | NELFINAVIR | Dideoxynucleosides - administration & dosage | Organophosphates - administration & dosage | Lamivudine - administration & dosage | Ritonavir - administration & dosage | HIV-1 - drug effects | Humans | Lopinavir | Pyrimidinones - therapeutic use | Organophosphates - therapeutic use | Carbamates - administration & dosage | HIV Protease Inhibitors - administration & dosage | HIV-1 - genetics | Reverse Transcriptase Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Sulfonamides - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | HIV Infections - drug therapy | Dideoxynucleosides - therapeutic use | Pyrimidinones - administration & dosage | Reverse Transcriptase Inhibitors - therapeutic use | Carbamates - therapeutic use | Drug Therapy, Combination | Sulfonamides - administration & dosage | Dosage and administration | Protease inhibitors | Comparative analysis | Drug therapy | HIV infection | Antiviral agents | Research | Drug therapy, Combination | Health aspects | Anti-HIV agents | Antiretroviral drugs | Human immunodeficiency virus--HIV | Samples | Clinical trials | Comparative studies | Clinical medicine | Disease control
Journal Article
AIDS (London, England), ISSN 0269-9370, 2007, Volume 21, Issue 9, pp. 1119 - 1127
Journal Article